(1)
Outcome of Combined Temozolomide CCNU Versus Temozolomide (Standard or Extended) For Patients With Methylated MGMT Glioblastoma. J. Can. Res. Updates 2026, 15 (3), 197-205. https://doi.org/10.30683/1929-2279.2026.15.18.